Folic‐Acid‐Mediated Functionalized Gold Nanocages for Targeted Delivery of Anti‐miR‐181b in Combination of Gene Therapy and Photothermal Therapy against Hepatocellular Carcinoma
Source abstract
Abstract
Therapeutic strategies based on modulation of microRNAs (miRNAs) activity hold much promise for cancer therapy, but for clinical applications, the efficient delivery of miRNAs to tumor cells or tumor tissues remains a great challenge. In this work, microRNA‐181b inhibitor (anti‐miR‐181b) is successfully condensed into polyethyleneimine (PEI)‐modified and folate receptor (FR)‐targeted PEGylated gold nanocages (AuNCs). This delivery system is designated as anti‐miR‐181b/PTPAuNCs nanocomplexes (PTPAuNC‐NPs), which begin with chemical modification of AuNCs with SH‐PEG5000‐folic acid (SH‐PEG5000‐FA) and SH‐PEG5000 through a gold–sulfur bond, followed by conjugating PEI using lipoic acid as a linker. Finally anti‐miR‐181b is condensed via electrostatic interactions. In vitro and in vivo experiments show that PTPAuNC‐NPs can efficiently deliver anti‐miR‐181b into target sites to suppress tumor growth, and considerably decrease tumor volumes in SMMC‐7721 tumor‐bearing nude mice under near‐infrared radiation. All these results suggest that PTPAuNC‐NP gene delivery system with combination of gene therapy and photothermal therapy will be of great potential use in future cancer therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · MicroRNA in disease regulation · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences Zhengzhou University 100 Kexue Avenue Zhengzhou 450001 P. R. China
The First Affiliated Hospital of Zhengzhou University 1 Construction Road Zhenzhong 450052 P. R. China
Department of Pharmacy Yanzhou People's Hospital 99 Jianshe xi Road Jining 272100 P. R. China
Collaborative Innovation Center of New Drug Research and Safety Evaluation Henan Province Zhengzhou 450001 P. R. China
Academy of Medical Science Zhengzhou University Zhengzhou 450052 P. R. China
Funding
National Natural Science Foundation of China
References (49)
Show source-provided references
1. Ma L. · Discovery Med. · 2015 · 19 · 7
2. 10.1016/j.jhep.2011.07.00710.1016/j.jhep.2011.07.007 ↗
3. Farazi P. A. · Discovery Med. · 2006 · 6 · 182
4. 10.1038/clpt.2012.19210.1038/clpt.2012.192 ↗
5. 10.1038/onc.2008.27410.1038/onc.2008.274 ↗
6. 10.1158/0008-5472.CAN-11-114410.1158/0008-5472.CAN-11-1144 ↗
7. 10.1002/hep.2672010.1002/hep.26720 ↗
8. 10.1371/journal.pone.007965510.1371/journal.pone.0079655 ↗
9. 10.1093/carcin/bgs13010.1093/carcin/bgs130 ↗
10. 10.1038/onc.2009.46810.1038/onc.2009.468 ↗
11. 10.1016/j.addr.2014.05.00910.1016/j.addr.2014.05.009 ↗
12. 10.1016/j.bbrc.2006.12.13510.1016/j.bbrc.2006.12.135 ↗
13. 10.1038/nature0479110.1038/nature04791 ↗
14. 10.1038/nrc296610.1038/nrc2966 ↗
15. 10.1016/j.jconrel.2013.09.01510.1016/j.jconrel.2013.09.015 ↗
16. 10.1016/j.addr.2014.10.03110.1016/j.addr.2014.10.031 ↗
17. 10.1038/mt.2012.6710.1038/mt.2012.67 ↗
18. 10.1016/j.biomaterials.2012.12.01610.1016/j.biomaterials.2012.12.016 ↗
19. 10.1016/j.biomaterials.2013.11.03910.1016/j.biomaterials.2013.11.039 ↗
20. 10.1016/j.addr.2012.05.00410.1016/j.addr.2012.05.004 ↗
21. 10.1021/nn800370j10.1021/nn800370j ↗
22. 10.1016/j.addr.2010.03.01110.1016/j.addr.2010.03.011 ↗
23. 10.1038/nature1232710.1038/nature12327 ↗
24. 10.3109/1061186X.2014.93140510.3109/1061186X.2014.931405 ↗
25. 10.1016/j.biomaterials.2014.12.03510.1016/j.biomaterials.2014.12.035 ↗
26. 10.1016/j.biomaterials.2014.12.02010.1016/j.biomaterials.2014.12.020 ↗
27. 10.1016/j.biomaterials.2014.12.04010.1016/j.biomaterials.2014.12.040 ↗
28. 10.1007/s10555-008-9155-610.1007/s10555-008-9155-6 ↗
29. 10.1038/nprot.2007.32610.1038/nprot.2007.326 ↗
30. 10.1002/adfm.20140228910.1002/adfm.201402289 ↗
31. 10.1016/j.jconrel.2010.02.00510.1016/j.jconrel.2010.02.005 ↗
32. 10.1016/j.biomaterials.2014.08.02210.1016/j.biomaterials.2014.08.022 ↗
33. 10.1038/nprot.2008.24310.1038/nprot.2008.243 ↗
34. 10.1002/adhm.20140002610.1002/adhm.201400026 ↗
35. 10.1016/j.biomaterials.2012.09.03710.1016/j.biomaterials.2012.09.037 ↗
36. 10.1016/j.jcis.2011.09.01310.1016/j.jcis.2011.09.013 ↗
37. 10.1073/pnas.72.3.93710.1073/pnas.72.3.937 ↗
38. 10.1021/nn900215k10.1021/nn900215k ↗
39. 10.1038/gt.2010.11710.1038/gt.2010.117 ↗
40. 10.1016/j.bbamem.2012.07.01110.1016/j.bbamem.2012.07.011 ↗
41. Bahmani B. · Int. J. Nanomed. · 2013 · 8 · 1609
42. 10.1021/bc100308p10.1021/bc100308p ↗
43. 10.1021/ja412735p10.1021/ja412735p ↗
44. 10.4155/tde.11.7210.4155/tde.11.72 ↗
45. 10.1021/ar200061q10.1021/ar200061q ↗
46. 10.1002/adfm.20100132910.1002/adfm.201001329 ↗
47. Fu M. · Int. J. Clin. Exp. Pathol. · 2013 · 6 · 2185
48. 10.1371/journal.pone.009993210.1371/journal.pone.0099932 ↗
49. 10.1021/nn303022310.1021/nn3030223 ↗